DONATE
Français
Ontario
Alberta and Northwest Territories
British Columbia and Yukon
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Cancer information
Loading...
Support & services
Loading...
Prevention & screening
Loading...
Get involved
Loading...
DONATE
Menu
Loading...
Links
Research Horizons
Trending Topics:
HPV
clinical trial
T cell therapy
immunotherapy
Home
Close
immunotherapy
The immune system’s quality control: eliminating cells that could lead to cancer
early diagnosis
Liquid biopsies: promise in lung cancer
genomics
Using existing drugs in a new way to treat bone cancer
prevention
Working the night shift might prevent DNA repair
Research Institute
Merck Canada
Research Impact Report
Prevention Network
Canadian Cancer Trials
News: clinical trial
New prostate cancer treatment significantly improves survival
Personalized medicine: Transforming cancer treatment
Pushing for more effective therapies
Immunotherapy shows promise for mesothelioma
Will immunotherapy transform cancer care?
New treatment combination for prostate cancer recurrence
Tackling the fear of cancer recurrence
The Crucial Role of Patient Samples in Cancer Research
New Hope for Elderly Patients with Glioblastoma
CRISPR gene-editing trial tests new way to treat cancer
New laser treatment offers hope for prostate cancer patients
Using genetic clues to guide cancer treatment
Supported by:
Next
Canadian Cancer Society
Fighting since 1938
Our mission
Our research
A message from our chair
Our partnerships
Our people
News
Research horizons
Ethical fundraising
Resource publications
Impact report
Financial statements
About our site & information
Our editorial policy
Medical disclaimer
Privacy policy
Linking policy
Accessibility
Terms and conditions
If you need support or have any questions, contact us.
Talk to us
1-888-939-3333
Monday to Friday
TTY
1-866-786-3934
Email us